Target intelligence / Profile preview

MicroRNA 29a-5p (miR-29a-5p)

Target
miR-29a-5p
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 29a-5p (miR-29a-5p) is a small non-coding RNA molecule that belongs to the miR-29 family, which also includes miR-29b and miR-29c. While the -3p strand is often the dominant guide strand, miR-29a-5p (the passenger strand) has been identified as a significant regulator in various pathological conditions, including cancer, neurodegeneration, and traumatic brain injury. It primarily functions through post-transcriptional gene silencing by binding to the 3'-untranslated regions of target mRNAs such as ARID2, DHRS4, and NLRP3, thereby modulating pathways related to cell proliferation, epithelial-mesenchymal transition, and inflammation. In the central nervous system, miR-29a-5p has been shown to act as an unconventional ligand for Toll-like receptor 7 (TLR7), contributing to neuroinflammation and neuronal injury in Alzheimer's disease models. Conversely, its role in traumatic brain injury suggests a protective effect by suppressing the NLRP3 inflammasome. Therapeutic strategies targeting miR-29a-5p involve the use of synthetic mimics to restore its tumor-suppressive or anti-inflammatory functions, or antagomirs to inhibit its potentially harmful effects in neurodegenerative contexts.

Other names
hsa-miR-29a-5pmiR-29a*MIR29AMicroRNA 29a passenger strand
02

Mechanism of action

Post-transcriptional gene silencing via binding to the 3'-untranslated region (3'-UTR) of target mRNAs; also functions as a Toll-like receptor 7 (TLR7) agonist in the central nervous system.

03

Biological functions

Gene silencingRegulation of translationApoptosisCell proliferationCell migrationCell invasionAutophagy inhibitionNeuroinflammationMicroglial activationExtracellular matrix regulation
04

Disease associations

CancerTraumatic brain injuryAlzheimer's diseaseFibrosisDepressionHepatocellular carcinomaGliomaPancreatic cancer
05

Safety considerations

Off-target effectsNeurotoxicityImmune activationDelivery challengesStability in circulation
06

Interacting drugs

miR-29a-5p mimic

1 more in the full profile.

07

Biomarkers

Serum miR-29a-5p levelsTissue miR-29a-5p expressionExosomal miR-29a-5p

Beyond the preview

Go deeper on MicroRNA 29a-5p (miR-29a-5p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 29a-5p (miR-29a-5p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call